Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures (BASE)
A 12-Month Noninterventional, Postmarketing, Multicenter Study to Evaluate the Effectiveness of Briviact® (Brivaracetam) as Adjunctive Therapy in Patients With Epilepsy With Partial-onset Seizures in Daily Clinical Practice
Sponsor: Pharm Research Associates Ltd. UK
Listed as NCT02687711, this observational or N/A phase trial focuses on Epilepsy With POS With or Without Secondary Generalization and remains completed. Sponsored by Pharm Research Associates Ltd. UK, it has been updated 33 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
33 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Feb 2025 — Sep 2025 [monthly]
Completed
-
Sep 2024 — Feb 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Sep 2021 — Jul 2024 [monthly]
Completed
▶ Show 28 earlier versions
-
Jun 2021 — Sep 2021 [monthly]
Completed
-
Jan 2021 — Jun 2021 [monthly]
Completed
-
Aug 2020 — Jan 2021 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jul 2020 — Aug 2020 [monthly]
Active Not Recruiting
-
Jun 2020 — Jul 2020 [monthly]
Active Not Recruiting
-
Apr 2020 — Jun 2020 [monthly]
Active Not Recruiting
-
Mar 2020 — Apr 2020 [monthly]
Active Not Recruiting
-
Dec 2019 — Mar 2020 [monthly]
Active Not Recruiting
-
Nov 2019 — Dec 2019 [monthly]
Active Not Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2019 — Oct 2019 [monthly]
Recruiting
-
May 2019 — Jun 2019 [monthly]
Recruiting
-
Mar 2019 — May 2019 [monthly]
Recruiting
-
Jan 2019 — Mar 2019 [monthly]
Recruiting
-
Dec 2018 — Jan 2019 [monthly]
Recruiting
-
Nov 2018 — Dec 2018 [monthly]
Recruiting
-
Oct 2018 — Nov 2018 [monthly]
Recruiting
-
Jul 2018 — Oct 2018 [monthly]
Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Mar 2018 — Apr 2018 [monthly]
Recruiting NA
-
Jan 2018 — Mar 2018 [monthly]
Recruiting NA
-
Dec 2017 — Jan 2018 [monthly]
Recruiting NA
-
Oct 2017 — Dec 2017 [monthly]
Recruiting NA
-
Aug 2017 — Oct 2017 [monthly]
Recruiting NA
-
Jun 2017 — Aug 2017 [monthly]
Recruiting NA
-
Feb 2017 — Jun 2017 [monthly]
Recruiting NA
-
Jan 2017 — Feb 2017 [monthly]
Recruiting NA
First recorded
Feb 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Pharm Research Associates Ltd. UK
- UCB Biopharma S.P.R.L.
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
A Coruña, Spain , Aarhus, Denmark , Badajoz, Spain , Berlin, Germany , Birmingham, United Kingdom , Bonn, Germany , Budapest, Hungary , Cardiff, United Kingdom , Cork, Ireland , Córdoba, Spain and 31 more locations